MANAGEMENT TEAM

DR. CHRISTOPHER TING
GROUP MD/CEO
-
Co-founder of Biomark and CEO of Innovative Diagnostics
-
Founder of Quantum Diagnostics
-
Former CEO of Quest Laboratories and Gribbles Pathology
-
Previously Assistant Head (Biomedical Sciences Group) at the Economic Development Board of Singapore
-
Member in Malaysia's National Key Economic Area (NKEA) Healthcare initiative

NABIL FAWZI
GROUP DEPUTY CEO / CFO
-
Over 18 years of corporate experience including 8 years of Corporate Finance and Mergers & Acquisitions expertise
-
Previously led EY Asia Pacific's healthcare CF/M&A space
-
Also served with PwC Singapore and UEM Group, a subsidiary of Khazanah Nasional

RAJKUMAR RENGARAJU
GROUP COO
-
More than 18 years of experience in the medical laboratory industry
-
Spearheaded multiple quality initiatives including CAP and ISO 15189 accreditation; and Westgard Verification
-
Led and managed multiple mergers and laboratory rollout's

CHRIS SKENNERTON
GROUP CTO
-
30 years in digital innovation and transformation, operations, software engineering and lab information systems
-
Previously with 4Cyte Pathology, Healius, GE Healthcare and Royal Australian Air Force

MARTIN GIDDY
GROUP PMO
-
Has over 30 years of experience in medical laboratory operations, in university teaching hospitals and private laboratories
-
Previously CEO of Quantum Diagnostics and GM of Gribbles
-
Managed the implementation of NATA and Standard Malaysia's ISO 17025 and ISO 15189 accreditations for Gribbles Pathology